A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients. - Gasser O; Sharples KJ; Barrow C; Williams GM; Bauer E; Wood CE; Mester B; Dzhelali M; Caygill G; Jones J; Hayman CM; Hinder VA; et al. (Cancer immunology, immunotherapy : CII, 2018)